Researchers characterize unusual blood clots in leprosy patients

March 22, 2018, Public Library of Science
A deep vein inflammatory infiltrate with wall dissociated by edema, observed in a skin lesion of a leprosy patient suffering an erythema nodosum leprosum episode. Credit: Lara, et al. 2017

For years, doctors have observed that some patients with leprosy develop unusual blood clots which can lead to stroke or heart attack. Now, researchers reporting in PLOS Neglected Tropical Diseases have for the first time characterized these blood clots, leading to a new understanding of how leprosy affects the circulatory system and potential new screening tests to predict leprosy reactions.

Leprosy is a chronic infection by Mycobacterium leprae and causes body-wide symptoms, deformities, and disability. It remains a public health problem worldwide, despite the existence of antibiotic combinations that can cure it. While many symptoms are due to the bacteria's infection of immune and nervous system cells, reactional episodes of leprosy also include symptoms and disorders more closely linked to hemostasis, or clotting.

Flavio Alves Lara of the Oswaldo Cruz Institute, and colleagues searched for blood clotting abnormalities among 638 leprosy and identified 35 patients who had unusual fatty clots, which the researchers dubbed "leprosum clots." The team went on to study what factors predicted the development of leprosum clots and what molecules were present in the clots.

The researchers found that patients both experiencing a reactional episode and those with non-reactional leprosy had factors in their blood—including plasmatic fibrinogen, anti-cardiolipin antibodies, von Willebrand factor, and soluble tissue factor— promoting blood coagulation. Formation of leprosum clots, they showed, was correlated with increased levels of soluble tissue factor and von Willebrand factor. Tests on leprosum clots revealed high contents of lipids and fibrinogen, and showed higher levels of two proteins—complement component 3 and 4 and inter-alpha- trypsin inhibitor family heavy chain-related protein (IHRP)—compared to clots from patients without leprosy.

"We propose that some of these components, fibrinogen for example, presents potential as predictive biomarkers of reactions, generating tools for earlier diagnosis and treatment of these events," the researchers say.

Explore further: Immune suppressant ineffective in treating leprosy inflammation

More information: Silva DSd, Teixeira LAC, Beghini DG, Ferreira ATdS, Pinho MdBM, Rosa PS, et al. (2018) Blood coagulation abnormalities in multibacillary leprosy patients. PLoS Negl Trop Dis 12(3): e0006214. doi.org/10.1371/journal.pntd.0006214

Related Stories

Immune suppressant ineffective in treating leprosy inflammation

March 30, 2017
Throughout the course of a leprosy infection, patients often have episodes of painful inflammation affecting their skin and nerves. Researchers have continuously struggled with finding effective drugs to treat these so-called ...

India had 56% of world's new leprosy infections in 2010

July 28, 2012
India accounted for 56 percent of the world's new leprosy infections in 2010 despite declaring itself free of the nerve-destroying disease five years earlier, a report said Saturday.

Leprosy's drug resistance and origin revealed by genome analysis

January 24, 2018
Leprosy is an infectious disease with gruesome symptoms. It damages the skin, peripheral nerves, the upper respiratory tract, and the eyes. Despite being curable with multidrug therapy, leprosy still persists in many developing ...

5 things you should know about leprosy

July 28, 2015
Leprosy is not common, but confirmed cases have jumped this year in Florida. There are usually 0-12 new cases of leprosy reported in the state every year. However, nine cases have been reported already. That's more cases ...

Leprosy strain genotyped from medieval pilgrim at UK burial site

January 26, 2017
Leprosy is a bacterial infection caused by Mycobacterium leprae or Mycobacterium lepromatosis. It has afflicted humans for thousands of years, reaching epidemic levels during the Middle Ages, and people continue to be affected ...

Recommended for you

Antibody 'cocktail' can prevent Zika infection but is not effective for treatment of fetuses

April 26, 2018
A "cocktail" of monoclonal antibodies that can prevent Zika virus (ZIKV) infection in primates was not effective for treatment of fetuses, according to a new collaborative study led by a University of Miami Miller School ...

E. coli—are we measuring the wrong thing?

April 25, 2018
A sepsis awareness and management programme has demonstrated overall success in terms of improved sepsis detection, but has led to an increase in the number of E. coli blood stream infection cases presented, calling into ...

Malaria study reveals gene variants linked to risk of disease

April 25, 2018
Many people of African heritage are protected against malaria by inheriting a particular version of a gene, a large-scale study has shown.

Commonly prescribed heartburn drug linked to pneumonia in older adults

April 24, 2018
Researchers at the University of Exeter have found a statistical link between pneumonia in older people and a group of medicines commonly used to neutralise stomach acid in people with heartburn or stomach ulcers. Although ...

Kids with rare rapid-aging disease get hope from study drug

April 24, 2018
Children with a rare, incurable disease that causes rapid aging and early death may live longer if treated with an experimental drug first developed for cancer patients, a study suggests.

Early treatment for leg ulcers gets patients back on their feet

April 24, 2018
Treating leg ulcers within two weeks by closing faulty veins improves healing by 12 per cent compared to standard treatment, according to new findings.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.